MDMA Assisted Therapy for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Feb 2022: Trial registered, NCT05219175
  2. 16 Apr 2024: Trial started, NCT05219175

The trials

NCT05219175: MDMA for Co-occurring PTSD and OUD After Childbirth

State
Under way
Phase
Phase 2
People
15 planned
Started
16 Apr 2024
Primary completion
Apr 2027
Arms
Co-occurring PTSD and OUD prior and after treatment with MDMA Assisted Therapy
Results
None posted
  1. 1 Feb 2022: Trial registered
  2. 16 Apr 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.